Efficacy and Safety of Mexartan Potassium Tablets (AZL-M) and Calcium Channel Blockers (CCB) in the Treatment of Adults With Essential Hypertension in Chinese Population: a National Multicenter, Prospective, Observational Study
Clinical trial NCT05947448 · UNKNOWN
Trial details
- NCT number
- NCT05947448
- Sponsor
- Hasten Biopharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-01-22
- Primary completion
- 2025-06-30
- Enrollment
- 1215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.